hrp0098fc10.1 | Multisystem Endocrine Disorders | ESPE2024

Genetic screening and tumour surveillance program outcomes in rare paediatric hereditary endocrine tumour syndromes

Oprea Alina , Izatt Louise , Ajzensztejn Michal , Snow Emma , Carroll Paul , Wei Christina

Background: Hereditary syndromic endocrine tumours are associated with significant morbidity in the paediatric population. Advances in molecular genetics enable early cascade genetic testing with early initiation of tumour screening. Controversy exists around the start age and burdens arising from screening-related harms.Objective: To describe the efficiency of the screening program for paediatric patients with genetic r...

hrp0098fc10.2 | Multisystem Endocrine Disorders | ESPE2024

Characterising the natural history of Multiple Endocrine Neoplasia 2B caused by M918T RET pathogenic variants in children and young people

McGlacken-Byrne Sinead , Butler Colin , Abdel Aziz Tarek , Izatt Louise , Brain Caroline , Kurzawinski Tom

Aim: We describe the natural history, treatment, and clinical outcomes of Multiple Endocrine Neoplasia type 2B (MEN2B) caused by the M918T RET pathogenic variant.Methods: Retrospective case notes review of all young people <18 years presenting to a quaternary paediatric endocrinology referral centre in the UK between 2005-2023 who have MEN2B caused by the M918T pathogenic variant in the RET proto-onc...

hrp0089fc5.5 | Thyroid | ESPE2018

Guidelines for the Management of Paediatric Differentiated Thyroid Carcinoma; a UK Endeavour

Howard Sasha , Newbold Kate , Freeston Sarah , Natu Sonali , Pomplun Sabine , Izatt Louise , Gaze Mark , Barney Harrison , Spoudeas Helen , Wilne Sophie

Objectives: Differentiated thyroid cancer (DTC) has shown increasing incidence in children and young people <19 years (CYP), and CYP present with more extensive disease than in adults and are at risk of long-term morbidity. A paucity of randomised controlled trials in the field has led to a lack of consensus on how these children should best be managed. These Children’s Cancer and Leukaemia Group and British Society for Paediatric Endocrinology and Diabetes commission...

hrp0089fc9.6 | Pituitary, neuroendocrinology and Puberty 1 | ESPE2018

National UK Guidelines for Screening, Multi-Disciplinary Team Management and Long-Term Follow-Up of Children and Young People (CYP) with Multiple Endocrine Neoplasia Type 1 (MEN1)

Crowne Elizabeth , Prasad Rathi , Newey Paul , Bradley Karin , Charnley Richard , Doran Helen , Callaway Mark , Mayhew Jonathan , Shine Brian , Izatt Louise , Spoudeas Helen , Harrison Barney

Background: The management of MEN1 in CYP<19 years is challenging due to its rarity, and diverse presentations of its component tumours to several adult and paediatric medical and surgical specialists. There is little high quality evidence for treatment recommendations.Aim: To ensure age- and tumour-specific paediatric and adult teams are involved in co-ordinated discussions to improve high quality care and hence survival and reduce long term morbidi...

hrp0095rfc1.1 | Thyroid | ESPE2022

European Thyroid Association Guideline on the Management of Pediatric Thyroid Nodules and Thyroid Carcinoma

Lebbink Chantal A. , Links Thera P. , Czarniecka Agnieszka , Dias Renuka P. , Elisei Rossella , Izatt Louise , Krude Heiko , Lorenz Kerstin , Luster Markus , Newbold Kate , Piccardo Arnoldo , Sobrinho Simões Manuel , Takano Toru , Paul van Trotsenburg A.S. , Verburg Frederik A. , van Santen Hanneke M.

At present no European recommendations for the management of pediatric thyroid nodules and differentiated thyroid carcinoma (DTC) exist. Differences in clinical, molecular, and pathological characteristics between pediatric and adult DTC emphasize the need for specific recommendations for the pediatric population. An expert panel was instituted by the executive committee of the European Thyroid Association (ETA) including an international community of experts from a variety of...